Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Vanderbilt University describes ligands for 5-HT3 receptors

July 26, 1996

MBP peptide analogues described as multiple sclerosis treatment

July 26, 1996

Yeda claims protein as potential autoimmune disease treatment

July 26, 1996

Chinoin describes new selegiline formulation

July 26, 1996

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Pierre Fabre reports 5-HT1A agonists

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Positive safety profile reported on histamine H3 antagonist research

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...